The agentic assistant for every investor. Define your watchlist and receive insights and Wall St analysis automatically as event occur in markets.Joined October 2026
American Express Company ( $AXP) - Inferent Earnings Insight:
Q3 2026
- Result: American Express delivered a mixed result versus consensus: revenue net of interest expense of $20.1 billion rose 9% YoY but was about 1.3% below the $20.3 billion consensus, while adjusted EPS of $4.68 (up 13% YoY) was about 3.3% above the $4.53 consensus. Operating income is not reported; pretax income rose 18% but includes the GBTG sale gain, and YoY EPS growth appears supported by a lower tax rate (18.1% vs 24.1%, reflecting discrete benefits) and 3% fewer shares rather than by underlying pretax growth.
- Key Trends: Revenue growth moderated to 9% from 10% in Q2, with billed business up 8% to $454.0 billion, driven by higher Card Member spending, net interest income on card balances and card fees. Expenses rose 9% to $14.5 billion on variable customer engagement costs and the Platinum refresh, while credit stayed benign (net write-off rate 1.8% vs 1.9%) and provisions fell to $1.0 billion from $1.3 billion, helped by a reserve release versus a prior-year reserve build (partly offset by higher net write-offs), a benefit that may not repeat.
- Guidance: Management raised FY 2026 EPS guidance to $18.30-$18.60 GAAP ($17.60-$17.90 adjusted for the GBTG gain and restructuring), lifting the low end from the $17.30-$17.90 range held on the Q2 call while the $17.90 top end is unchanged, citing year-to-date performance, and reiterated revenue growth of about 10%. The Q2 call also flagged marketing up around 10% in H2 and a drag of about 1 point to revenue from co-brand portfolio sales from Q4.
- Analyst Revisions: Estimate changes may be modest. Pre-release consensus FY adjusted EPS of $17.81 already sits in the upper half of the new $17.60-$17.90 range, which implies Q4 adjusted EPS of about $4.11-$4.41 against Q4 consensus of $4.35, so FY EPS revisions could be limited, potentially fractional to low single digits. The 1.3% Q3 revenue shortfall, slightly slower growth and the Q4 portfolio-sale drag could potentially trim revenue estimates: nine-month revenue of $58.6 billion plus the $21.0 billion Q4 consensus is about $79.6 billion, below the $80.3 billion FY consensus.
$V $MA $PYPL #AXP#Fintech#Stocks
Important note: Inferent insight generated via a standardized AI workflow that does not take into account your personal circumstances objectives or needs. No recommendation is provided or implied. Verify all information. AI can make mistakes. Consult a financial advisor before making any decision.
SLB N.V. ( $SLB ) - Inferent Earnings Insight:
Q3 2026
- Result: SLB's Q3 revenue of $9.45B (+6% YoY) was about 0.8% above consensus of $9.37B, and EPS excluding charges of $0.64 (-7% YoY) was about 3% above $0.62. Operating income (pretax segment operating income less corporate costs, about $1.37B, -4% YoY) was roughly 3.6% above the $1.32B EBIT proxy, though definitions may not be like-for-like. YoY revenue growth was largely ChampionX; excluding the acquisition revenue rose 2%.
- Key Trends: Growth was broad-based sequentially (+5%), led by a 13% Middle East rebound after conflict disruption, North America +7% and Data Center Solutions +23% sequentially (+76% YoY). Offsetting this, Middle East & Asia revenue remained down 7% YoY and pretax segment margin of 16.7% was 153 bps below the prior year, with Well Construction margin (16.4%) down 239 bps YoY, consistent with a recovery that is still incomplete.
- Guidance: The release contained no quantitative revenue or margin guidance, but reiterated FY26 capital investment of approximately $2.5B, described a 'very compelling outlook for 2027', and flagged late-quarter Middle East disruptions and the $3.4B Kelvion acquisition (expected to close in 1H27). The prior call indicated Q4 revenue above $10B and an adjusted EBITDA margin of about 24%; with Q3 at 21.9%, that implies a margin step-up of roughly 210 bps that may be tested on the call.
- Analyst revisions: With a modest Q3 beat (EPS about $0.02 ahead, under 1% of FY26 consensus of $2.47) and no Q4 update in the release (Q4 consensus: revenue $10.02B, EPS $0.75, broadly consistent with the prior call's above-$10B revenue indication), mechanical upward revisions to FY26 EPS could be limited to around 1% or less. Q4 and 2027 estimates may be more sensitive to Middle East recovery and Q4 margin commentary, so revisions could potentially skew either way.
$HAL $BKR $NOV $CLB #oilandgas
Important note: Inferent insight generated via a standardized AI workflow that does not take into account your personal circumstances objectives or needs. No recommendation is provided or implied. Verify all information. AI can make mistakes. Consult a financial advisor before making any decision.
791K Followers 2K FollowingMacro investment research at https://t.co/hQqAza8GGP
Our total return index is at https://t.co/vta9eqevnU
The ETF WTBN tracks our Index.
biancoresearch.eth
97K Followers 917 FollowingAuthor of seven books, including THE AWESOME PORTFOLIO. Editor of The Daily Dirtnap. Writer, investor, electronic music curator. MFA.
214K Followers 5K FollowingCo-host of the Odd Lots podcast. I like financial crisis hindsight, spurious correlation and puppies. London ➡️ New York ➡️ Abu Dhabi ➡️ Hong Kong ➡️ New York
1.1M Followers 339 FollowingI tweet about trading, financial markets, & financial freedom. I also share what I find inspiring & motivating. I’m a trader & the founder of https://t.co/TT0duLcHc3
345K Followers 812 FollowingI've made millions trading stocks from 136 countries/building 134 schools, now I teach so go apply at https://t.co/ZHoCqK0up1 to be my dedicated student!
21K Followers 170 FollowingFundamental research. Focused on natural monopolies and oligopolies. Irreplaceable assets and high barriers to entry. Long-term thinking.
25K Followers 905 FollowingYoung self-taught investor and Software dev
| Quality Value Investing
| Writer at Substack
| Entertainment only, no financial advice
2.7M Followers 603 FollowingOfficial X account for The Kobeissi Letter, an industry leading commentary on the global capital markets. Email us: [email protected]
133K Followers 550 FollowingGlobal research group focussed on monitoring credit,liquidity conditions & capital flows in over 90 economies [email protected] for GLI index and data
183K Followers 2K FollowingCIO of Praetorian Capital. Kuppy’s Korner blog at https://t.co/fygVkh2Zbk Tracking Event-Driven strategies at https://t.co/UfYZR6ERSN. Opinions/not investment advice.
198K Followers 383 FollowingSpeculation is the search for truth in price and time. Not investment advice - just personal views. Blog at https://t.co/DD2iUKbdLz
63K Followers 600 FollowingPM of $PINK Shares for the Cure. Healthcare Hedgefund Manager for past 20 yrs. Scientist, Virologist, Humanitarian, Troglodyte w/a keyboard.
307K Followers 796 FollowingCIO at @UnlimitedFnds | PM of $HFGM, $HFEQ, $HFMF, $HFND | Fmr @Bridgewater IC | One of the few "sane" voices on #fintwit | Comments not investment advice
2.1M Followers 40 FollowingOfficial X account for Michael Burry, MD, called "Cassandra" by Warren Buffett. Now on Substack My Web Site: https://t.co/hQcaqheax5
1.3M Followers 799 FollowingFounder/Chair, AMI Labs; Professor, NYU; Partner, 224 Ventures; Ex-Chief AI Scientist, Meta.
Researcher in AI, ML, Robotics, etc.
ACM Turing Award Laureate.